SDI Share Price

Open 0.35 Change Price %
High 0.35 1 Day -0.01 -2.86
Low 0.34 1 Week 0.00 0.00
Close 0.34 1 Month 0.00 0.00
Volume 81500 1 Year 0.00 0.00
52 Week High 9.21
52 Week Low 2.11
SDI Important Levels
Resistance 2 0.35
Resistance 1 0.35
Pivot 0.34
Support 1 0.33
Support 2 0.33
TSE Canada Most Active Stocks
BIN 41.40 -1.62%
BIN 41.40 -1.62%
LSG 2.08 8.33%
LSG 2.08 8.33%
LSG 2.08 8.33%
TBE 0.03 0.00%
BTO 3.19 -5.62%
BTO 3.19 -5.62%
PLI 2.00 4.71%
PLI 2.00 4.71%
More..
TSE Canada Top Gainers Stocks
TVI 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
DA-A 0.22 22.22%
INQ 4.08 21.79%
INQ 4.08 21.79%
CTU-A 0.25 19.05%
MM 0.07 16.67%
MM 0.07 16.67%
More..
TSE Canada Top Losers Stocks
GBV 0.46 -24.59%
LRT-UN 0.07 -22.22%
TLB 0.60 -16.67%
TLB 0.60 -16.67%
RKN 1.62 -12.43%
RKN 1.62 -12.43%
PWC 0.08 -11.11%
PWC 0.08 -11.11%
ORA 0.16 -11.11%
ORA 0.16 -11.11%
More..

Spectral Diagnostics Inc (TSE: SDI)

SDI Technical Analysis 3
As on 30th Dec 2014 SDI Share Price closed @ 0.34 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.35 & Sell for SHORT-TERM with Stoploss of 0.34 we also expect STOCK to react on Following IMPORTANT LEVELS.
SDI Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
SDI Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.spectraldx.com
SDI Address
SDI
135-2 The West Mall
Toronto, ON M9C 1C2
Canada
Phone: 416-626-3233
Fax: 416-626-7383
Interactive Technical Analysis Chart Spectral Diagnostics Inc ( SDI TSE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Spectral Diagnostics Inc
SDI Business Profile
Spectral Diagnostics Inc. develops and commercializes theranostic treatment for severe sepsis in North America. The company’s products include Endotoxin Activity Assay, a rapid diagnostic test for detection of components of gram negative bacterial cell wall; and Toraymyxin, a therapeutic hemoperfusion device for the treatment of sepsis that removes endotoxin from the bloodstream. It is also involved in the development, production, and marketing of recombinant cardiac proteins, antibodies, and calibrators for use in research and development, as well as in products manufactured by other diagnostic companies. The company was founded in 1991 and is headquartered in Toronto, Canada.